申请人:Kyorin Pharmaceutical Co., Ltd.
公开号:US06071950A1
公开(公告)日:2000-06-06
Novel N-substituted pyrrolidine derivatives having a highly selective and potent antagonism against smooth muscle muscarine receptors and being useful for the treatment of irritable bowel syndrome and the like, characterized by being represented by general formula (1) wherein R represents a hydrogen atom, a halogen atom, or a lower alkoxy group and a process for preparing the same.
具有高度选择性和强效拮抗平滑肌毒蕈碱受体的新型N-取代吡咯烷衍生物,可用于治疗肠易激综合征等疾病,其特征在于由一般式(1)所代表,其中R代表氢原子、卤素原子或较低的烷氧基,并提供一种制备该化合物的方法。